In her own words:
"The true measure of progress in medicines innovation is not the registration of a new product, but whether people have access to treatments they need. Many of the laws and policies that support access to medicines are the result of informed and sustained activism."

A lawyer and public health advocate with over 30 years of experience, Ellen has led global initiatives including Médecins Sans Frontières (MSF) Campaign for Access to Essential Medicines and the Medicines Patent Pool, and has been recognised as one of the 50 most influential people in intellectual property.

📅 Join us to hear her insights at the Medicines Justice Conference (28-29 October 2025)
 🔗 Programme: https://lnkd.in/etKKnhvt
📝 Registration: https://lnkd.in/eMcXJYeX

Full bio of dr. Ellen 't Hoen:

Ellen ‘t Hoen, LLM PhD, is a lawyer and public health advocate with over 30 years of experience working on pharmaceutical and intellectual property policies. From 1999 until 2009 she was the director of policy for Médecins sans Frontières’ Campaign for Access to Essential Medicines. In 2009 she joined UNITAID in Geneva to set up the Medicines Patent Pool (MPP). She was the MPP’s first executive director until 2012. Between 2005 and 2021 she was listed five times as one of the 50 most influential people in intellectual property by the journal Managing Intellectual Property. She has worked as an advisor to a number of governments, NGOs and international organisations. She is currently a researcher at the University Medical Centre at the University of Groningen, The Netherlands. In 2020, she was appointed Officer of the Order of Oranje-Nassau, a royal award given by the King of the Netherlands for her international work on equitable access to affordable medicines. She has published widely on medicines law and policy issues. Her book “Private Patents and Public Health: Changing intellectual property rules for public health” published July 2016 was awarded the 2017 Prix Prescrire for a “major reference work on access to medicines” by French healthcare journal La Revue Prescrire. She has a Masters of Laws from the University of Amsterdam and a PhD from the University of Groningen.